Company

for wound healing

BROTHIER

at a glance

150
employees
90 / 100
gender equality score (2023 Gender Equality Index)
52
million euros in sales (2023)
14 %
sales revenue invested in R&D and clinical studies
20
distribution countries
0
batch recalls and stock-outs
100 %
MDs devised and manufactured in France
100 %
MDs made from seaweed

BROTHIER

an independent French SME, founded in 1949



Specialising in the use of biopolymers extracted from algae, for the purposes of haemostasis and wound healing.
From the middle of the 20th century, Brothier, a global pioneer in the field of calcium alginates, developed the first industrial procedures for transforming the biopolymers contained in algae into textile form.

The high-technology dressings, cavity ropes, pad dressings and powders obtained in this way are used for a number of medical purposes, from the treatment of epistaxis to the care of highly complex wounds in a hospital setting.

BROTHIER

an independent French SME, founded in 1949

THE VISION

of the president

« Our credo is to remain French and independent, thus maintaining our freedom of action and our long-term vision. In the context of globalisation, our industrial and scientific programs focus on France, although they have an international presence. Very recently, a major investment has been made in our Research and Production site, to address market dynamics and to meet the future quality and safety needs for surgery-related products. »

Christian Girardière

BROTHIER

a few key dates